These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3348945)

  • 1. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.
    Christiansen H; Lampert F
    Br J Cancer; 1988 Jan; 57(1):121-6. PubMed ID: 3348945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor cytogenetics and prognosis in neuroblastoma].
    Christiansen H; Lampert F
    Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour karyotype may be important in the prognosis of human neuroblastoma.
    Franke F; Rudolph B; Christiansen H; Harbott J; Lampert F
    J Cancer Res Clin Oncol; 1986; 111(3):266-72. PubMed ID: 3733856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma.
    Christiansen H; Franke F; Bartram CR; Adolph S; Rudolph B; Harbott J; Reiter A; Lampert F
    Cancer Genet Cytogenet; 1987 Jun; 26(2):235-44. PubMed ID: 3567877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.
    Longo L; Christiansen H; Christiansen NM; Cornaglia-Ferraris P; Lampert F
    J Cancer Res Clin Oncol; 1988; 114(6):636-40. PubMed ID: 3204111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
    Hayashi Y; Kanda N; Inaba T; Hanada R; Nagahara N; Muchi H; Yamamoto K
    Cancer; 1989 Jan; 63(1):126-32. PubMed ID: 2910410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma: clinical significance of genetic abnormalities.
    Brodeur GM
    Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
    Schwab M
    Brain Pathol; 1990 Sep; 1(1):41-6. PubMed ID: 1669692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
    Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N
    Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
    Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different karyotypic patterns in early and advanced stage neuroblastomas.
    Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M
    Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
    N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
    Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG
    Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.